Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Test method: GH.

M Bidlingmaier1, Z Wu, C J Strasburger

  • 1Department of Internal Medicine, Klinikum Innenstadt, Ludwig-Maximilians-University, Munich, Germany.

Bailliere'S Best Practice & Research. Clinical Endocrinology & Metabolism
|August 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First 100 patients receiving long-acting growth hormone therapy: real-world evaluation from INSIGHTS-GHT registry.

Orphanet journal of rare diseases·2025
Same author

Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society.

Pituitary·2025
Same author

Retraction Note: Influence of hypobaric hypoxia on leptin levels in men.

International journal of obesity (2005)·2024
Same author

Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.

Pituitary·2021
Same author

Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.

Pituitary·2021
Same author

Linkage between growth retardation and pituitary cell morphology in a dystrophin-deficient pig model of Duchenne muscular dystrophy.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society·2020
Same journal

Inhibin B in the assessment of seminiferous tubular function.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Post-Chernobyl thyroid carcinoma in children.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Surgical approach to thyroid nodules and cancer.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Diagnosis and treatment of medullary thyroid cancer.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Management of undifferentiated thyroid cancer.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Papillary and follicular thyroid carcinoma.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
See all related articles

Detecting recombinant human growth hormone (GH) abuse in sports is challenging due to its similarity to natural GH. New methods using GH isoforms and related parameters offer promising solutions for identifying doping.

Area of Science:

  • Sports Science
  • Biochemistry
  • Endocrinology

Background:

  • Recombinant human growth hormone (GH) abuse is prevalent in sports, yet detection remains difficult.
  • Existing detection methods are limited by GH's similarity to endogenous forms and secretion patterns.
  • The International Olympic Committee (IOC) prohibits GH but lacks a validated detection test.

Purpose of the Study:

  • To address the challenge of detecting recombinant human GH (rhGH) abuse in athletes.
  • To explore novel methods for identifying rhGH administration despite physiological complexities.

Main Methods:

  • Utilizing differential immunoassays to analyze GH isoforms in circulation.
  • Monitoring changes in GH-dependent biomarkers following rhGH administration.

Related Experiment Videos

Main Results:

  • Differential immunoassays can distinguish between endogenous and recombinant GH isoforms.
  • Specific changes in GH-dependent parameters indicate rhGH use.

Conclusions:

  • New detection strategies based on GH isoforms and biomarkers are feasible.
  • These advancements offer a pathway to effectively combat rhGH doping in sports.